Skip to main content
Explore URMC

PKUDOS: Phenylketonuria (PKU) Demographic, Outcomes, and Safety Registry

Research Question:
Is the drug Kuvan safe when used to treat patients with phenylketonuria?

Basic Study Information

The objective of this study is to evaluate the safety of long-term treatment with Kuvan.

Location: University of Rochester Medical Center

Study Contact Information

Study Coordinator: Caroline Moore
Phone: (651) 523-0310

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search